Setran en es it fr

Setran Brand names, Setran Analogs

Setran Brand Names Mixture

  • No information avaliable

Setran Chemical_Formula


Setran RX_link

No information avaliable

Setran fda sheet

Setran msds (material safety sheet)

Setran Synthesis Reference

No information avaliable

Setran Molecular Weight

309.469 g/mol

Setran Melting Point

< 25 oC

Setran H2O Solubility

Soluble as HCl salt

Setran State


Setran LogP


Setran Dosage Forms

Tablets (oral, 1 mg)

Setran Indication

Used for the symptomatic treatment of parkinsonism.

Setran Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Setran Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Setran side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Setran Patient Information

Setran Organisms Affected

Humans and other mammals